APR 14, 202663 MINS READ
The structural foundation of hydrogel biodegradable materials relies on carefully designed polymer networks incorporating hydrolyzable linkages that enable controlled degradation. Photocrosslinked biodegradable hydrogels utilize natural polymer macromers—such as alginate, hyaluronic acid, or dextran—crosslinked through hydrolyzable acrylate bonds 1. This approach addresses the limitations of ionically crosslinked systems by providing precise control over mechanical properties, swelling ratios, and degradation profiles while maintaining cytocompatibility 2. The hydrolyzable acrylate crosslinks undergo predictable scission under physiological conditions, producing substantially non-toxic degradation products that can be metabolized or excreted 1.
Alternative crosslinking strategies employ β-aminoester linkages formed between acrylate-functionalized water-soluble polymers and amine-containing components 9. This chemistry enables gelation at body temperature without external catalysts, offering advantages for in situ forming systems. The β-aminoester bonds provide tunable degradation rates through hydrolysis, with degradation kinetics adjustable via polymer molecular weight and crosslink density 9. Schiff base crosslinking represents another elegant approach, particularly for injectable formulations combining aldehyde-modified hyaluronic acid with amine-functionalized gelatin 12. This reversible covalent chemistry yields hydrogels with excellent viscoelasticity and mechanical properties while maintaining biodegradability and biocompatibility 12.
Polyurethane-based biodegradable hydrogels incorporate hydrolyzable functional groups within the polymer backbone, formed by reacting polyisocyanate prepolymers with polyols containing ester or carbonate linkages 68. These systems degrade within six months through hydrolysis of the incorporated ester groups, producing non-toxic degradation products with pH values exceeding 5.0 6. The degradation timeline aligns with wound healing processes, providing temporary adhesion barrier function without long-term foreign body presence 8. Critical design parameters include:
Thermosensitive biodegradable hydrogels exhibit reverse thermal gelation, transitioning from low-viscosity liquids at room temperature to semi-solid gels at physiological temperature. This behavior enables minimally invasive injection followed by in situ gelation, eliminating the need for surgical implantation 45. The most extensively studied systems comprise amphiphilic block copolymers with hydrophilic polyethylene glycol (PEG) segments and hydrophobic biodegradable polyester blocks such as polycaprolactone (PCL) or poly(lactic-co-glycolic acid) (PLGA) 414.
MPEG-PCL copolymer hydrogels demonstrate lower critical solution temperatures (LCST) ranging from 20–45°C, with the transition temperature precisely tunable through copolymer composition and molecular weight 4. Below the LCST, the copolymers exist as unimers or small micelles in aqueous solution with viscosities of 50–200 mPa·s 4. Upon heating to body temperature (37°C), hydrophobic interactions drive micelle aggregation and physical network formation, increasing viscosity by 2–3 orders of magnitude to 10,000–50,000 mPa·s within 2–5 minutes 514. This sol-gel transition is thermoreversible, though the hydrogel maintains structural integrity in vivo due to continuous body temperature 4.
The hydrophobic polyester segments provide biodegradability through hydrolytic cleavage of ester bonds, with degradation rates controllable via polyester type, molecular weight, and block ratio 45. PCL-based systems typically degrade over 3–6 months, while PLGA incorporation accelerates degradation to 1–3 months 14. Critically, the hydrolysis products maintain pH > 5.0, avoiding the acidic microenvironment and inflammatory responses associated with bulk PLGA degradation 4. The hydrophilic PEG segments (typically 500–2,000 Da) are excreted renally following network dissolution 4.
Enhancement of cell adhesion in thermosensitive systems has been achieved through conjugation of cell-adhesive peptides such as RGD (Arg-Gly-Asp) sequences to the MPEG-PCL backbone 514. This modification maintains thermosensitivity intact while providing integrin-binding sites that promote cell attachment, spreading, and proliferation 5. Comparative studies demonstrate 3–5 fold increases in cell adhesion and 2-fold improvements in cell viability for peptide-modified versus unmodified thermosensitive hydrogels 14. Key formulation parameters include:
Biodegradable single-phase cohesive hydrogels employ interpenetrating network (IPN) architectures to overcome the inverse relationship between injectability and in vivo persistence that limits conventional single-network systems 315. These materials comprise 2–5 independently crosslinked polymers—typically hyaluronic acid derivatives with varying molecular weights (500 kDa to 2 MDa)—that are mixed post-crosslinking to form a homogeneous interpenetrating structure 315. The crosslinked polymers are insoluble in water yet miscible with each other, creating a densely interlaced network without covalent bonds between different polymer chains 15.
The IPN architecture provides several technical advantages. First, the interpenetration of multiple crosslinked networks increases the overall network density and entanglement, enhancing resistance to enzymatic degradation (particularly hyaluronidase) by 40–60% compared to single-network hydrogels of equivalent polymer concentration 715. Second, the rheological properties—viscosity, elasticity (G'), and loss modulus (G'')—can be independently optimized by adjusting the molecular weight distribution and crosslink density of individual polymer components before mixing 315. This enables formulations with high elasticity (G' = 200–800 Pa) for structural persistence combined with moderate viscosity (10,000–50,000 mPa·s) for injectability through fine-gauge needles (25–30 G) 3.
Third, the single-phase cohesive nature ensures reproducible and homogeneous properties throughout the hydrogel volume, avoiding the phase separation and inconsistent degradation observed in biphasic or particle-containing systems 15. Clinical applications include dermal fillers for wrinkle correction, where persistence of 9–18 months is achieved while maintaining smooth injection and natural tissue integration 315. The biodegradation occurs through combined hydrolytic and enzymatic pathways, with degradation products (primarily disaccharides and oligosaccharides) cleared via lymphatic drainage and metabolism 15.
Polymer hydrogel complexes incorporating polyphenolic compounds or metal ions represent another IPN strategy for enhancing biostability and mechanical properties 7. Complexation with tannic acid or epigallocatechin gallate increases resistance to hyaluronidase degradation by 50–70% while imparting antioxidant activity (DPPH radical scavenging >60%) and antibacterial properties (>90% inhibition of S. aureus and E. coli growth) 7. The polyphenolic compounds form multiple hydrogen bonds and hydrophobic interactions with polymer chains, reinforcing the network without covalent modification 7. Mechanical testing demonstrates 2–3 fold increases in compressive modulus (from 5–10 kPa to 15–30 kPa) and tensile strength (from 10–20 kPa to 30–50 kPa) for complexed versus uncomplexed hydrogels 7. Design considerations include:
Photocrosslinking provides spatial and temporal control over hydrogel formation, enabling in situ polymerization and patterning for tissue engineering applications 1217. The process involves dissolving polymer macromers functionalized with photoreactive groups (typically methacrylate or acrylate) in aqueous solution, adding a photoinitiator, and exposing to UV (320–365 nm) or visible light (400–500 nm) 117. Riboflavin-based photoinitiator systems offer advantages for biomedical applications due to biocompatibility and visible light activation 17.
For dextran methacrylate hydrogels, a representative protocol employs 10–20 wt% polymer solution with 0.01–0.1 wt% riboflavin and 0.5–2.0 wt% L-arginine or chitosan as co-initiator, exposed to 400–500 nm light at 5–20 mW/cm² for 5–30 minutes 17. The riboflavin/L-arginine system generates radicals through electron transfer mechanisms, initiating free radical polymerization of methacrylate groups 17. Gelation time decreases from 15 minutes to 3 minutes as light intensity increases from 5 to 20 mW/cm², while gel fraction (crosslinked polymer percentage) increases from 75% to 95% 17.
Critical process parameters include:
Thermosensitive biodegradable hydrogels require careful formulation to achieve appropriate sol-gel transition temperatures and gelation kinetics 4514. Synthesis begins with preparation of amphiphilic block copolymers through ring-opening polymerization of cyclic esters (ε-caprolactone, lactide, glycolide) using methoxy-PEG as macroinitiator and stannous octoate catalyst (0.1–0.5 mol% relative to monomer) 414. Polymerization proceeds at 110–130°C under nitrogen for 24–48 hours, yielding copolymers with controlled block lengths and narrow molecular weight distributions (polydispersity index 1.1–1.3) 14.
The copolymers are dissolved in phosphate-buffered saline or cell culture medium at 4°C with stirring for 12–24 hours to ensure complete dissolution 45. Concentration is adjusted to 15–30 wt% based on desired gelation temperature and gel strength 4. For cell or drug encapsulation, the components are added to the cold polymer solution and mixed gently to avoid bubble formation 514. The formulation remains liquid during storage at 4°C (shelf life 6–12 months) and injection at room temperature, then gels within 30 seconds to 5 minutes upon warming to 37°C 45.
Peptide conjugation for enhanced cell adhesion involves activating carboxyl groups on the copolymer with EDC/NHS chemistry (molar ratio 1:2:0.5 for COOH:EDC:NHS) in aqueous solution at pH 5.5–6.0 for 30 minutes, followed by addition of amine-terminated peptide (0.1–1.0 mol% relative to polymer) and reaction at room temperature for 4–12 hours 514. Unreacted reagents are removed by dialysis (molecular weight cutoff 3,500 Da) against water for 48 hours with frequent water changes 14. Key formulation parameters include:
Michael addition reactions between acrylate and thiol or amine groups provide catalyst-free crosslinking suitable for cell encapsulation and in situ gelation 9. A representative system employs 4-arm or 8-arm PEG-acrylate (10–20 wt%, 5,000–20,000 Da) mixed with PEG-amine or dithiothreitol (DTT) at stoichiometric ratios (1:1 acrylate:nucleophile) 9. Gelation occurs within 5–30 minutes at room temperature or 37°C through nucleophilic addition to the acrylate double bond, forming β-aminoester or thioether linkages 9.
The β-aminoester bonds are hydrolyzable, providing biodegradability with half-lives of 2–8 weeks depending on pH and temperature 9. Degradation accelerates at pH > 8 due to base-catalyzed ester hydrolysis, while acidic conditions (pH < 6) slow degradation 9. This pH-responsive behavior enables applications such as controlled urea release in agricultural hydrogels, where high pH from ammonia volatilization triggers gel swelling and slows nutrient release 13. Thioether linkages formed with thiol crosslinkers are non-degradable, requiring incorporation of hydrolyzable segments in the polymer backbone for biodegradability 9.
Process optimization parameters include:
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| CASE WESTERN RESERVE UNIVERSITY | Tissue engineering scaffolds for 3D cell cultivation and regenerative medicine applications requiring controlled degradation and cell encapsulation. | Photocrosslinked Alginate Hydrogel System | Utilizes hydrolyzable acrylate crosslinks to achieve precise control over mechanical properties, swelling ratios, and degradation profiles while maintaining cytocompatibility and producing non-toxic degradation products. |
| LABORATORIES VIVACY | Aesthetic medicine applications including wrinkle correction and soft tissue augmentation requiring long-term persistence with smooth injection properties. | Single-Phase Cohesive Dermal Filler | Interpenetrating network architecture of 2-5 crosslinked hyaluronic acid polymers provides 40-60% enhanced resistance to hyaluronidase degradation and 9-18 months persistence while maintaining injectability through 25-30G needles. |
| INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | Minimally invasive drug delivery systems, cell delivery vehicles, and injectable tissue engineering scaffolds requiring in situ gelation without surgical implantation. | MPEG-PCL Thermosensitive Hydrogel | Exhibits reverse thermal gelation with LCST of 20-45°C, transitioning from low viscosity liquid to gel at body temperature within 2-5 minutes, with degradation producing non-toxic products (pH>5.0) over 3-6 months. |
| THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION | Tissue regeneration applications requiring enhanced cell attachment and proliferation, particularly for soft tissue repair and regenerative medicine. | RGD-Modified MPEG-PCL Hydrogel | Cell-adhesive peptide conjugation provides 3-5 fold increase in cell adhesion and 2-fold improvement in cell viability while maintaining thermosensitive gelation properties and biodegradability. |
| BAYER MATERIALSCIENCE AG | Surgical adhesion barriers for abdominal and pelvic surgery requiring temporary protection during wound healing without long-term foreign body presence. | Polyurethane-Based Adhesion Barrier | Biodegrades within 6 months through hydrolysis of ester groups, producing non-toxic degradation products (pH>5.0), providing temporary adhesion prevention aligned with wound healing timeline. |